Trius Therapeutics Inc's ROA from the second quarter of 2013 to the second quarter of 2012 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Trius Therapeutics Inc's ROA in the second quarter of 2013?
Trius Therapeutics Inc recorded a cumulative net loss of $-69 million during 12 months ending in the second quarter of 2013, resulting in a negative return on assets (ROA) of -86.25%.

However, within the Healthcare sector 400 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2013 from 4283 to 4455.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2013) II. Quarter	(Mar 31 2013) I. Quarter	(Dec 31 2012) IV. Quarter	(Sep 30 2012) III. Quarter	(Jun 30 2012) II. Quarter
Y / Y Total Assets Change	-21.85 %	-15.7 %	10.49 %	4.22 %	55.02 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-69	-64	-54	-40	-8
Return On Assets (TTM)	-86.25 %	-74.8 %	-60.45 %	-45.41 %	-8.9 %
TSRX's Total Ranking	# 4455	# 4283	# 4220	#	#
Total Assets (TTM) in million	74	90	75	80	95
Seq. Total Assets Change	-17.55 %	19.32 %	-6.2 %	-15.31 %	-11.06 %
Seq. Net Income Change	-	-	-	-	-

TSRX's 5 Years Annual ROA >> Back to TSRX Management Effectiveness >> Compare TSRX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 48
Sector	# 401
Overall	# 3560

Return On Assets Statistics
High	Average	Low
-60.45 %	-73.84 %	-86.25 %
		(Jun 30 2013)

Financial Statements
Trius Therapeutics Inc's Assets	$ 74 million	TSRX's Balance sheet
Trius Therapeutics Inc's Income	$ -20 million	Quarterly TSRX's Income Statement
TSRX's Income by Division		See TSRX's Income by Division

Annual Return On Assets	(Dec 31 2012) FY 2012	(Dec 31 2011) FY 2011	FY	FY	FY
Y / Y Total Assets Change	10.49 %	-	-	-	-
Total Assets in million	75	68	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-54	-18	0	0	0
Annual Return On Assets	-71.64 %	-26.79 %	-	-	-

TSRX's 5 Years Annual ROA >> Back to TSRX Management Effectiveness >> Compare TSRX ROA to its Competitors

More Return On Assets Ratios
TSRX's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TSRX's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TSRX's Competitors
Subscribers only: Roa for Trius Therapeutics Inc's Suppliers
Subscribers only: Return On Assets for TSRX's Customers

You may also want to know
TSRX's Roi	TSRX's Inventory Turnover Ratio	TSRX's Growth Rates	TSRX's Dividend Comparisons
	TSRX's Profitability Ratios	TSRX's Asset Turnover Ratio	TSRX's Dividend Growth
TSRX's Roe	TSRX's Valuation Ratios	TSRX's Financial Strength Ratios	TSRX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2013, within Healthcare Sector

ROA

Date modified: 2026-09-18T13:11:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.